 |
|
European Commission proposes strict ethical guidelines on EU funding of human embryonic stem cell research
July 14, 2003Today the Commission adopted a proposal for guidelines on EU-funded human embryonic stem cell research.
The EU 6th Research Framework Programme (FP6 2003-2006), as adopted by the Council of Ministers and the European Parliament in 2002, allows for the funding of human embryonic stem cell research in relation to the fight against major diseases. Such research, in particular when it involves the derivation of stem cells from human supernumerary embryos, can only take place within a framework of clear and strict ethical guidelines.
The EU research programme includes ethical provisions related to sensitive areas of research. In light of the sensitive nature of human embryonic stem cell research, the Council and the Commission agreed at the time of the decision-making process on FP6 that further ethical guidelines would be adopted before the end of 2003 for deciding on and for monitoring the EU funding of human embryonic stem cell research. Today's proposal presents a coherent set of strict ethical guidelines that will apply to the EU funding of research projects involving the derivation of stem cells from human supernumerary embryos. In parallel, the Commission is publishing a call for proposals for the set-up of a European registry of stem cells and for contributing to the establishment of public stem cell banks. In this way, the EU will contribute to an optimal access to and use of stem cells, ensuring that the results of research ultimately become more quickly available to all patients across Europe.
Research Commissioner Philippe Busquin said : « The decision to fund human embryonic stem cell research from the Sixth Framework Programme was already taken by Council and Parliament last year. By funding this research and by setting strict ethical rules for such funding, the EU contributes in a responsible way to advancing this science for the benefit of patients across the world, while at the same time ensuring that it takes place within a clear ethical framework. »
Stem cell research
Stem cells are basic cells that multiply and differenciate into specialised cells, tissue and even organs. Stem cell research is a promising area of biotechnology for human health. It offers the prospect of developing new methods to repair or replace tissues or cells damaged by injuries or diseases and to treat serious chronic diseases such as Parkinson's or Alzheimer's as well as more common diseases such as diabetes. Stem cell research is expected to provide a better understanding of human life and of disease development. It will lead to the development of safer and more effective drugs. It does, however, raise ethical questions when stem cells are derived from human supernumerary embryos.
The scope of the Commission proposal
The Commission proposal does not aim to set universal ethical principles, which is not a role for the EU. It does not aim to provide guidelines for EU Member States either, since every Member State must decide for itself on this issue. The Commission proposal only sets out the conditions for EU (FP6) research involving the derivation of stem cells from human supernumerary embryos. The proposal is fully in line with the various opinions of the European Group on Ethics (EGE), in particular opinion n°15 of November 14, 2000, "Ethical aspects of human stem cell research and use". The Framework Programme respects national rules and values as no funding is made available for a specific research activity in a Member State where that research is forbidden.
The stem cell debate
Funding for human embryonic stem cell research has always been possible under previous Framework Programmes and any project related to this issue was subject to an ethical review by a broad group of experts in the field. In the decision-making process on the Specific Programmes implementing FP6, the Council and the Commission agreed that additional guidelines on human embryonic stem cell research would be put in place before the end of 2003. During that period, no projects involving derivation of new stem cell lines from human supernumerary embryos would be funded. The Commission committed itself to submitting a legislative proposal identifying these guidelines, on which the European Parliament will be consulted. The three Institutions agreed to reach a decision on this issue before the end of 2003.
The opinion of the European Group on Ethics
The EGE identified the following principal requirements regarding human embryonic stem cell research and the procurement of embryonic stem cells from supernumerary embryos:
"˘ Free and informed consent from the donating couple or woman.
"˘ Approval of the research by an authority.
"˘ No financial gain for donors.
"˘ Anonymity of the donors and protection of the confidentiality of personal information of the donors.
"˘ Transparency regarding research results.
Guidelines for human embryonic stem cell research at EU level
The Commission proposal deals with a very precise research topic, namely the derivation of stem cells from supernumerary embryos with no parental project. These embryos, maximum 5 to 7 days old and of a microscopic dimension, are frozen as a result of in-vitro fertilisation (IVF) treatment and are donated by parents for research. They will, at some point, be disposed of without being used either for IVF or for research purposes. The proposal does not aim to create human embryos for the purpose of stem cell procurement, including by means of somatic cell nuclear transfer, (commonly referred to as therapeutic cloning). The creation of human embryos for research is explicitly excluded from the scope of FP6 funding. To meet a concern that EU funding would provide indirect incentives for the production of more embryos than needed for IVF, the Commission proposes that only supernumerary embryos can be used that were created before 27 June 2002, the date of adoption of the EU 6th Research Framework Programme.
FP6 funding for the derivation of new stem cells will only be made available if proposals successfully pass a rigorous scientific peer-review and an ethical review, for which this proposal suggests the criteria. The derivation of stem cells from supernumerary embryos is only one element in the broader EU approach to stem cell research, which also includes funding for adult (somatic) stem cells, training of researchers in this field, etc.
What exactly is the Commission proposing?
The Commission's proposal acknowledges that this issue is controversial, with many open questions, but also recognises the potential it offers for curing diseases and principle of freedom of research which is enshrined in the European Charter of Fundamental Rights. It proposes the following guidelines:
"˘ The EU will not fund human embryonic stem cell research where it is forbidden by a Member State;
"˘ Human embryonic stem cells can only be derived from supernumerary embryos that are donated for research by parents and that were created before 27 June 2002, the date of the adoption of the Framework Programme. These embryos are destined to be destroyed at some point in time;
"˘ Potential research project partners applying for EU funding must seek ethical advice at national or local level in Member States where the research will take place, even in countries where obtaining such ethical advice is not mandatory;
"˘ Research will be funded only when it is demonstrated that it meets particularly important research objectives;
"˘ Research will be funded only when there is no adequate alternative available. In particular, it must demonstrated that one cannot use existing embryonic or adult stem cell lines;
"˘ Supernumerary embryos will be used only if informed consent has been given by the donor(s);
"˘ Embryo donor(s) will not be permitted to make any financial gain;
"˘ Data and privacy protection of donors must be guaranteed;
"˘ Traceability of stem cells will be required;
"˘ Research consortia will be required to engage in making available new human embryonic stem cells to other researchers.
The Commission intends to fund the creation of a European registry, an initiative advocated by nearly all Member States. Such a registry at European level should reduce the need for derivation of stem cells from human supernumerary embryos in the future.
Collaborative research at EU level should contribute to a reduction of the use of human embryos. By sharing resources and results within a European project, duplication of research activities will be reduced. Furthermore, more rapid scientific progress can be achieved by bringing together multidisciplinary teams.
European Commission, Research Directorate
Stem Cells Current Events and Stem Cells News RSSDormant stem cells for emergencies
Many specialized cells, such as in the skin, intestinal mucosa or blood, have a lifespan of only a few days. For these tissues to function, a steady replenishment of specialized cells is indispensable. This is the task of so-called "adult" stem cells also known as tissue stem cells.
Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder
Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study prepublished online in Blood, the official journal of the American Society of Hematology.
New 'control knobs' for stem cells identified
Natural changes in voltage that occur across the membrane of adult human stem cells are a powerful controlling factor in the process by which these stem cells differentiate, according to research published by Tufts University scientists.
Children's Hospital scientists achieve repair of injured heart muscle in lab tests of stem cells
Researchers at Children's Hospital of Pittsburgh of UPMC have been able to effectively repair damaged heart muscle in an animal model using a novel population of stem cells they discovered that is derived from human skeletal muscle tissue.
Old flies can become young moms
Female flies can turn back the biological clock and extend their lifespan at the same time, University of Southern California biologists report.
Superglue from the sea
Sandcastle worms live in intertidal surf, building sturdy tube-shaped homes from bits of sand and shell and their own natural glue.
Pure insulin-producing cells produced in mouse
Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs).
Adult stem cell breakthrough
The first tissue-engineered trachea (windpipe), utilising the patient's own stem cells, has been successfully transplanted into a young woman with a failing airway. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life.
First trachea transplant without immunosuppression
After 4 years of going from consultation to consultation, Claudia Castillo finally found a solution to her respiratory problems. The young Colombian woman suffered from a cough that took a long time to be diagnosed as tuberculosis.
First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells
Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure.
More Stem Cells Current Events and Stem Cells News Articles
 | The Stem Cell Divide: The Facts, the Fiction, and the Fear Driving the Greatest Scientific, Political, and Religious Debate of Our Time by Michael Bellomo There has been much recent debate about the merits, dangers, and nature of stem cell research. Some see in it the answer to every debilitating disease known to man, while others see it as a step away from human cloning. While the battle has raged, research is moving ahead, and California has already passed a measure that will give $3 billion in support to stem cell research. But as politics,... |
 | Stem Cell Research: Medical Applications And Ethical Controversy (The New Biology) by Joseph, Ph.D. Panno This is an informative reference to the technological advances, applications, and issues of stem cell research. The past few years have seen controversy and debate surrounding stem cell research. Because skin cells have the capability to divide - unlike most of the cells in our body - our skin can heal itself through the division of cells. Scientists have attempted to apply this concept to major... |
 | Essentials of Stem Cell Biology by Robert Lanza, E. Donnall Thomas, James Thomson, Roger Pedersen, John Gearhart, Brigid Hogan, Douglas Melton, Michael West This abridged version of the bestselling reference Handbook of Stem Cells, Two-Volume Set attempts to incorporate all the essential subject matter of the original two-volume edition in a single volume. The material has been reworked in an accessible format suitable for students and general readers interested in following the latest advances in stem cells, including full color presentation... |
 | The Stem Cell Controversy: Debating the Issues (Contemporary Issue Series) Stem cell research is headline news. Researchers are eager to move forward, state governments and private foundations are rushing to support it, and the sick and afflicted are desperate for its benefits. Yet powerful forces in our society—led by President George W. Bush—find it morally troubling and they are doing all in their powers to restrict its development beyond a very limited scale. ... |
 | Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical, and Political Issues Few recent advances in science have generated as much excitement and controversy as human embryonic stem cells. The potential of these cells to replace diseased or damaged cells in virtually every tissue of the body heralds the advent of an extraordinary new field of medicine. Controversy arises, however, because current techniques required to harvest stem cells involve the destruction of the... |
 | 100 Questions & Answers About Bone Marrow and Stem Cell Transplantation by Ewa Carrier, Gracy Ledingham This text is a patient-oriented guide to dealing with a bone marrow or stem cell... |
 | Stem Cell Now by Christopher Thomas Scott The essential account of the most important scientific advance—and most volatile ethical debate—of our time While many believe stem cell research holds the key to curing a wide range of ailments, others see this research as opening a Pandora’s box that will devalue human life. In Stem Cell Now, Christopher Scott—executive director of Stanford University’s Stem Cells and Society... |
 | Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns by Anthony G. Payne, David Steenblock We are standing at the threshold of a new and exciting medical era-an era of regeneration, rejuvenation, and renewal in which stems cells will set the stage for healing and in some cases, the restoration of injured, diseased, and debilitated tissues and organ. While stem cell therapy is still in its infancy, the field is rich with promise. The debate over the use of embryonic stem cells and... |
 | Human Stem Cell Manual: A Laboratory Guide Stem cells are self-replicating and undifferentiated, meaning their function is not yet cell, tissue, or organ-specific. Due to the unique nature of these cells, research into their biology and function holds great promise for therapeutic applications through replacement or repair of diseased and damaged cells. This reader-friendly manual provides a practical "hands on" guide to the culture of... |
 | Miracle Stem Cell Heart Repair: (For Heart Attack, Heart Failure and Bypass Patients) by Christian Wilde |
| © 2008 BrightSurf.com |